Merck & Co., Inc.'s Net Worth
$1.18 Billion
Who is Merck & Co., Inc.?
Merck & Co., Inc. has an estimated net worth of $1.18 Billion. This is based on reported shares across multiple companies, which include Pandion Therapeutics, Inc., OPGEN INC, BeiGene, Ltd., Organon & Co., ARQULE INC, NGM BIOPHARMACEUTICALS INC, SUTRO BIOPHARMA INC, and Menlo Therapeutics Inc..
SEC CIK
Merck & Co., Inc.'s CIK is 0000310158
Past Insider Trading and Trends
2016 was Merck & Co., Inc.'s most active year for acquiring shares with 8 total transactions. Merck & Co., Inc.'s most active month to acquire stocks was the month of January. 2016 was Merck & Co., Inc.'s most active year for disposing of shares, totalling 2 transactions. Merck & Co., Inc.'s most active month to dispose stocks was the month of January. 2019 saw Merck & Co., Inc. paying a total of $65,946,928.00 for 12,955,016 shares, this is the most they've acquired in one year. In 2021 Merck & Co., Inc. cashed out on 253,516,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
OPGEN INC (OPGN) Snapshot price: $0.3172
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +102.07% | 2.73M |
—
|
—
| 5.41M |
Jun 27
| |||
Form 4
| +81.13% | 1.2M |
—
|
—
| 2.68M |
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BeiGene, Ltd. (BGNE) Snapshot price: $153.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 31.59M |
—
|
—
| 31.59M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Organon & Co. (OGN) Snapshot price: $17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -253.52M |
—
|
—
|
0
|
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Pandion Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARQULE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |